Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip G Febbo

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Urology|August 25, 2018
The 17-Gene Genomic Prostate Score Assay Predicts Outcome After Radical Prostatectomy Independent of PTEN StatusCristina Magi-Galluzzi, Sudhir Isharwal, Sara M Falzarano, et al.
Cancer Cell|February 3, 2009
Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastomaTracy-Ann Read, Marie P Fogarty, Shirley L Markant, et al.
Urology Practice|August 10, 2023
The Impact of a Biopsy Based 17-Gene Genomic Prostate Score on Treatment Recommendations in Men with Newly Diagnosed Clinically Prostate Cancer Who are Candidates for Active SurveillanceKetan K Badani, Michael J Kemeter, Phillip G Febbo, et al.
The Prostate|November 30, 2012
Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathwaysJoseph C Klink, Alok K Tewari, Elizabeth M Masko, et al.
Oncotarget|April 29, 2016
Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: evidence for a biologically meaningful field effectCristina Magi-Galluzzi, Tara Maddala, Sara Moscovita Falzarano, et al.
Cancer Research|September 24, 2009
MYC activity mitigates response to rapamycin in prostate cancer through eukaryotic initiation factor 4E-binding protein 1-mediated inhibition of autophagyBala S Balakumaran, Alessandro Porrello, David S Hsu, et al.
Urology|April 30, 2017
Use of a 17-Gene Prognostic Assay in Contemporary Urologic Practice: Results of an Interim Analysis in an Observational CohortGregg Eure, Raymond Germany, Robert Given, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancerPhillip G Febbo, Jerome P Richie, Daniel J George, et al.
Molecular Cell|April 14, 2009
A genomic strategy to elucidate modules of oncogenic pathway signaling networksJeffrey T Chang, Carlos Carvalho, Seiichi Mori, et al.
JCO Precision Oncology|January 2, 2024
Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer CarePhillip G Febbo, Mina Allo, Emma B Alme, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Urology|August 25, 2018
The 17-Gene Genomic Prostate Score Assay Predicts Outcome After Radical Prostatectomy Independent of PTEN StatusCristina Magi-Galluzzi, Sudhir Isharwal, Sara M Falzarano, et al.
Cancer Cell|February 3, 2009
Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastomaTracy-Ann Read, Marie P Fogarty, Shirley L Markant, et al.
Urology Practice|August 10, 2023
The Impact of a Biopsy Based 17-Gene Genomic Prostate Score on Treatment Recommendations in Men with Newly Diagnosed Clinically Prostate Cancer Who are Candidates for Active SurveillanceKetan K Badani, Michael J Kemeter, Phillip G Febbo, et al.
The Prostate|November 30, 2012
Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathwaysJoseph C Klink, Alok K Tewari, Elizabeth M Masko, et al.
Oncotarget|April 29, 2016
Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: evidence for a biologically meaningful field effectCristina Magi-Galluzzi, Tara Maddala, Sara Moscovita Falzarano, et al.
Cancer Research|September 24, 2009
MYC activity mitigates response to rapamycin in prostate cancer through eukaryotic initiation factor 4E-binding protein 1-mediated inhibition of autophagyBala S Balakumaran, Alessandro Porrello, David S Hsu, et al.
Urology|April 30, 2017
Use of a 17-Gene Prognostic Assay in Contemporary Urologic Practice: Results of an Interim Analysis in an Observational CohortGregg Eure, Raymond Germany, Robert Given, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancerPhillip G Febbo, Jerome P Richie, Daniel J George, et al.
Molecular Cell|April 14, 2009
A genomic strategy to elucidate modules of oncogenic pathway signaling networksJeffrey T Chang, Carlos Carvalho, Seiichi Mori, et al.
JCO Precision Oncology|January 2, 2024
Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer CarePhillip G Febbo, Mina Allo, Emma B Alme, et al.
Pageof 8